HealthEquity (HQY) Expected to Announce Quarterly Earnings on Tuesday

HealthEquity (NASDAQ:HQY - Get Free Report) will likely be releasing its Q1 2026 earnings data after the market closes on Tuesday, June 3rd. Analysts expect HealthEquity to post earnings of $0.81 per share and revenue of $322.25 million for the quarter.

HealthEquity Stock Up 0.1%

NASDAQ:HQY traded up $0.13 on Friday, hitting $101.11. The stock had a trading volume of 960,737 shares, compared to its average volume of 809,286. The business's fifty day moving average is $89.41 and its 200 day moving average is $97.48. The company has a market cap of $8.75 billion, a PE ratio of 92.76, a P/E/G ratio of 1.60 and a beta of 0.45. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity has a 52 week low of $65.01 and a 52 week high of $115.59.

Insider Buying and Selling

In related news, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This trade represents a 13.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now owns 84,969 shares in the company, valued at $6,597,842.85. This trade represents a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Barrington Research restated an "outperform" rating and issued a $112.00 target price on shares of HealthEquity in a report on Friday, April 11th. The Goldman Sachs Group dropped their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their target price for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. KeyCorp dropped their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Finally, Wells Fargo & Company raised their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $112.33.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.